We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$98.4B
AUM Growth
-$2.76B
Cap. Flow
-$1.74B
Cap. Flow %
-1.77%
Top 10 Hldgs %
21.87%
Holding
3,216
New
68
Increased
954
Reduced
1,923
Closed
84

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$106M
2
CRH icon
CRH
CRH
+$105M
3
AMZN icon
Amazon
AMZN
+$102M
4
AAPL icon
Apple
AAPL
+$98.1M
5
SLV icon
iShares Silver Trust
SLV
+$83.3M

Sector Composition

Rank Sector Weight
1 Technology 25.18%
2 Healthcare 15%
3 Financials 13.74%
4 Consumer Discretionary 9.98%
5 Industrials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRS icon
2351
Leonardo DRS
DRS
$12B
$808K ﹤0.01%
48,372
-4,491
-8% -$75.8K
MLTX icon
2352
MoonLake Immunotherapeutics
MLTX
$1.55B
$806K ﹤0.01%
+14,137
New +$780K
AVO icon
2353
Mission Produce
AVO
$1.17B
$805K ﹤0.01%
83,208
+6,273
+8% +$66.5K
HOUS
2354
DELISTED
Anywhere Real Estate
HOUS
$798K ﹤0.01%
124,107
-6,261
-5% -$45.6K
COMP icon
2355
Compass
COMP
$9.4B
$797K ﹤0.01%
274,940
+20,409
+8% +$72.1K
AOSL icon
2356
Alpha and Omega Semiconductor
AOSL
$1.08B
$797K ﹤0.01%
26,707
-1,255
-4% -$39K
FLNA
2357
Filana Therapeutics
FLNA
$48.1M
$792K ﹤0.01%
47,623
-1,616
-3% -$32K
MDXG icon
2358
MiMedx Group
MDXG
$633M
$792K ﹤0.01%
108,591
+21,072
+24% +$157K
MAXN
2359
DELISTED
Maxeon Solar Technologies
MAXN
$792K ﹤0.01%
683
-2
-0.3% -$3.8K
KROS icon
2360
Keros Therapeutics
KROS
$221M
$791K ﹤0.01%
24,799
-2,183
-8% -$81.5K
AORT icon
2361
Artivion
AORT
$1.32B
$790K ﹤0.01%
52,137
-1,810
-3% -$29.3K
MYE icon
2362
Myers Industries
MYE
$1.29B
$790K ﹤0.01%
44,072
+3,875
+10% +$73K
DNUT icon
2363
Krispy Kreme
DNUT
$576M
$789K ﹤0.01%
63,233
-2,773
-4% -$38.7K
EVLO
2364
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$784K ﹤0.01%
200,000
+19,480
+11% +$133K
PEBO icon
2365
Peoples Bancorp
PEBO
$1.47B
$782K ﹤0.01%
30,828
+1,651
+6% +$43.9K
HIMS icon
2366
Hims & Hers Health
HIMS
$7.31B
$782K ﹤0.01%
124,346
-3,912
-3% -$29.1K
AD
2367
Array Digital Infrastructure
AD
$3.05B
$782K ﹤0.01%
18,200
-2,774
-13% -$89.9K
RCUS icon
2368
Arcus Biosciences
RCUS
$3.64B
$781K ﹤0.01%
43,490
-12,658
-23% -$254K
VVX icon
2369
V2X
VVX
$2.65B
$780K ﹤0.01%
15,100
+130
+0.9% +$6.53K
KFVG
2370
DELISTED
KraneShares CICC China 5G and Semiconductor Index ETF
KFVG
$778K ﹤0.01%
52,000
LQDT icon
2371
Liquidity Services
LQDT
$1.31B
$777K ﹤0.01%
44,112
-7,686
-15% -$134K
FG icon
2372
F&G Annuities & Life
FG
$3.67B
$777K ﹤0.01%
27,699
+7,878
+40% +$213K
SSYS icon
2373
Stratasys
SSYS
$774M
$777K ﹤0.01%
57,075
+12,911
+29% +$204K
WWW icon
2374
Wolverine World Wide
WWW
$1.55B
$776K ﹤0.01%
96,224
-5,481
-5% -$56.4K
GES
2375
DELISTED
Guess Inc
GES
$773K ﹤0.01%
35,742
-4,784
-12% -$101K

Similar funds

Credit Suisse's Q3 2023 Portfolio in Review

As of Q3 2023, Credit Suisse held 3,216 positions worth $98.4B, down 2.7% from $101B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.7%. Credit Suisse opened 68 new positions and exited 84, leaving the 3,216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2023 buy was CRH: 1,849,255 shares worth $101M.
  • Credit Suisse added most to Alibaba in Q3 2023, an estimated $106M increase.
  • Credit Suisse's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $321M.
  • Credit Suisse fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $24.8M.
  • Credit Suisse's ten largest holdings make up 22% of its $98.4B portfolio in Q3 2023.
  • Credit Suisse opened 68 new positions and closed 84 in Q3 2023.
  • Credit Suisse's portfolio value fell 2.7% quarter-over-quarter to $98.4B.

Based on Credit Suisse's 13F filing for Q3 2023, filed 13 Nov 2023.